EGFR‐mutant lung adenocarcinoma associated with antisynthetase syndrome successfully treated with osimertinib

Here, we report a rare case involving a 66‐year‐old man with epidermal growth factor receptor (EGFR)‐mutant lung adenocarcinoma and antisynthetase syndrome (ASS) treated with osimertinib. The patient presented with respiratory failure and bilateral pulmonary opacities; he was diagnosed with ASS acco...

Descripción completa

Detalles Bibliográficos
Autores principales: Hara, Reina, Kanazu, Masaki, Iwai, Ami, Kuge, Tomoki, Ishijima, Mikako, Uenami, Takeshi, Akazawa, Yuki, Yano, Yukihiro, Yamaguchi, Toshihiko, Mori, Masahide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088957/
https://www.ncbi.nlm.nih.gov/pubmed/33682361
http://dx.doi.org/10.1111/1759-7714.13920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088957/
https://www.ncbi.nlm.nih.gov/pubmed/33682361
http://dx.doi.org/10.1111/1759-7714.13920

Ejemplares similares